ASGCT News

Getting to Know Ralph Yaniz, LGMD2L Patient and Advocate

Kenji Rowel Lim | June 11, 2021

We talked to Ralph Yaniz about his experience with limb girdle muscular dystrophy type 2L (LGMD2L), his advocacy activities, and more.

Read Full Story

Global Speakers Address Developing Gene Therapies in Low- and Middle-Income Countries

Martín Bonamino, Ph.D. | June 03, 2021

Martín Bonamino, Ph.D., provides a recap of the first Annual Meeting session organized by ASGCT's Global Outreach Committee.

Annual Meeting

Read Full Story

Q&A with Bruce Pyenson

Francesca Cook, MPH | June 03, 2021

ASGCT Government Relations Committee Chair Francesca Cook talked to Bruce Pyenson about reinsurance and risk, U.S. healthcare, and how the system will need to adapt to regenerative therapies.

Annual Meeting

Read Full Story

Apply Now for 2021 Awards

ASGCT Staff | June 01, 2021

ASGCT is awarding nearly $1 million to our members to support career development, equity, and research on conditions disproportionately affecting minorities.

Read Full Story

COVID-19 Vaccines to the Rescue

Edith Pfister, Ph.D. | May 28, 2021

During this special symposium at the Annual Meeting, panelists Sarah Gilbert, Ph.D., Larry Corey, M.D., Gregory Poland, M.D., Ligia Pinto, Ph.D., Philip Dormitzer, M.D., Ph.D., and Stephen Russell, M.D., Ph.D. talked about lessons learned during the pandemic.

Annual Meeting

Read Full Story

An Interview with University of Oxford Professor Matthew Wood

Eoghan J. Mulholland, Ph.D. | May 27, 2021

Eoghan J. Mulholland, Ph.D., talked to University of Oxford professor Matthew Wood about the UK's new Nucleic Acid Therapy Accelerator (NATA).

Read Full Story

Gene Therapy Progress: Challenges and Opportunities

Emily Walsh Martin, Ph.D. | May 26, 2021

Emily Walsh Martin, Ph.D., recommends two sessions to watch from the 24th Annual Meeting. 

Annual Meeting

Read Full Story

Celebrating Milestones at the Presidential Symposium

Kenji Rowel Lim | May 25, 2021

Robert Martuza, M.D., who is known for his pioneering work on oncolytic viruses, discussed uniting genetic engineering, virology, immunology, and cancer research, during his talk at the 24th Annual Meeting.

Annual Meeting

Read Full Story

Regulatory Lessons Learned From COVID-19: Anomaly to Precedent

Megan Zoschg Canniere, PharmD | May 18, 2021

This summary highlights valuable insights from regulatory leaders at FDA and EMA, among other speakers, from the Annual Meeting session, Regulatory Lessons Learned From COVID-19: Anomaly to Precedent.

Annual Meeting

Read Full Story

There Has Never Been a Better Time to Get into Gene Editing, Doudna Says

Edith Pfister, Ph.D. | May 18, 2021

In a fireside chat on the first day of the 24th Annual Meeting, Jennifer Doudna said the field needs energetic, passionate people to bring ingenuity. 

Annual Meeting

Read Full Story

Watch Annual Meeting Sessions On Demand

ASGCT Staff | May 18, 2021

While we work to build pages on ASGCT.org that will house the meeting content, you can watch it on the meeting platform through August 13.

Annual Meeting

Read Full Story

Watch Dr. Doudna's Fireside Chat

ASGCT Staff | May 11, 2021

We are making Dr. Doudna's fireside chat available to everyone.

Annual Meeting

Read Full Story

Must-See Sessions for Tuesday, May 11

ASGCT Staff | May 10, 2021

Here are some sessions not to miss on May 11, the first day of the 24th Annual Meeting.

Annual Meeting

Read Full Story

How to Access the 24th Annual Meeting

ASGCT Staff | May 10, 2021

Before you attend the 24th Annual Meeting, here are some important links and tips to make the most of the premier event in gene and cell therapy.

Annual Meeting

Read Full Story

Congratulations to Our New Board Officers

ASGCT Staff | May 03, 2021

Please welcome four new members of the ASGCT Board of Directors, who will take office on June 1!

Read Full Story

Read the Annual Meeting Abstracts

ASGCT Staff | April 27, 2021

Read our collection of the latest gene and cell therapy research ahead of presentation at the 24th Annual Meeting.

Annual Meeting

Read Full Story